Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification

NCT ID: NCT02717702

Last Updated: 2019-08-19

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 125 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2016-08-10
• Study Completion Date: 2019-06-11

Brief Summary

Acute Coronary Syndrome (ACS) is a serious heart condition that is a leading cause of death in America. Cardiac stress testing is currently the best test to non-invasively identify which patients might be having ACS and may need more invasive testing such as a cardiac catheterization (placing a tube in the heart) for coronary angiogram (invasive mapping of the blood vessels of the heart). However, stress tests require imaging by highly trained specialists and even then may not correctly categorize a small minority of patients being evaluated for ACS.

Advances in blood tests may now allow detection of the very early stages of heart blood vessel blockage via a simple blood test. The investigators seek to determine whether these blood tests can help to better identify patients with ACS. The study will also store any extra blood sample that may be left over for future use.

Conditions

Acute Coronary Syndrome

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

ACS Patients

Subjects will be patients presenting to the Emergency Department for evaluation of ACS.

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Any patient presenting to the ED with clinical suspicion of ACS as determined by the treating emergency physician. These include symptoms including but not limited to chest pain, pressure, or burning sensation across the precordium.
• Age 40 years or older.
• As part of their usual clinical care, the subject is scheduled to have a cardiac stress test. This includes nuclear (adenosine, regadenosine, or other adjunct with SPECT), either pharmacologic (dobutamine) or exercise (treadmill) echocardiography, or cardiac magnetic resonance imaging. Prior cardiac testing or observation unit evaluation is not an exclusion criterion.

Exclusion Criteria

• Patient with cardiac marker diagnosis of acute myocardial infarction or who otherwise is not a candidate for a cardiac stress test.
• Evidence of serious arrhythmias or acute MI or ischemia on ECG
• Unstable vital signs: persistent (> 2 readings or over 2 hours) hypotension (systolic blood pressure < 80 mm Hg), pulse > 110 beats per minute.
• Any medical condition that would be worsened by cardiac stress
• Aortic aneurysm or dissection
• Active myocarditis or pericarditis
• Ventricular dysrhythmia or significant atrial dysrhythmia
• Severe or greater degree of aortic stenosis
• Acute or decompensated heart failure or pulmonary edema
• Pulmonary embolism
• Aortic aneurysm
• Patient is non-English speaking.
• Patient is incarcerated or a prisoner.
• Patient does not have capacity to consent.

• Minimum Eligible Age: 40 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Duke University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Alexander T Limkakeng, MD

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Duke University Medical Center

Durham, North Carolina, United States

Countries

United States

Other Identifiers

Pro00056764

Identifier Type: -

Identifier Source: org_study_id